nifedipine has been researched along with Intraventricular Septal Defects in 6 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Excerpt | Relevance | Reference |
---|---|---|
"We investigated the potential benefit of a preferential pulmonary vasodilatory effect of nifedipine in 4 patients with Eisenmenger syndrome complicating ventricular septal defect." | 9.07 | Improvement of exercise capacity after nifedipine in patients with Eisenmenger syndrome complicating ventricular septal defect. ( Cheng, CH; Lau, CP; Leung, WH; Wong, CK; Yeung, DW, 1991) |
"The hemodynamic effects of nifedipine in 15 patients with pulmonary hypertension (PH) secondary to congenital heart disease (CHD) were evaluated." | 7.67 | [Therapeutic effects of nifedipine in pulmonary hypertension secondary to congenital heart disease]. ( Bai, YR; Chen, H; Wang, SZ, 1989) |
"We investigated the potential benefit of a preferential pulmonary vasodilatory effect of nifedipine in 4 patients with Eisenmenger syndrome complicating ventricular septal defect." | 5.07 | Improvement of exercise capacity after nifedipine in patients with Eisenmenger syndrome complicating ventricular septal defect. ( Cheng, CH; Lau, CP; Leung, WH; Wong, CK; Yeung, DW, 1991) |
"The hemodynamic effects of nifedipine in 15 patients with pulmonary hypertension (PH) secondary to congenital heart disease (CHD) were evaluated." | 3.67 | [Therapeutic effects of nifedipine in pulmonary hypertension secondary to congenital heart disease]. ( Bai, YR; Chen, H; Wang, SZ, 1989) |
"The haemodynamic effects of nifedipine were studied in 14 patients (aged 8-14 years, seven male and seven female) with ventricular septal defect with and without pulmonary hypertension." | 3.67 | Acute haemodynamic effects of nifedipine in patients with ventricular septal defect. ( Berisha, S; Frasheri, A; Goda, A; Kastrati, A; Popa, Y, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hodges, R | 1 |
Barkehall-Thomas, A | 1 |
Tippett, C | 1 |
Khan, SA | 1 |
Gelb, BD | 1 |
Nguyen, KH | 1 |
Wong, CK | 1 |
Yeung, DW | 1 |
Lau, CP | 1 |
Cheng, CH | 1 |
Leung, WH | 1 |
Zhou, X | 1 |
Chen, H | 1 |
Wang, SZ | 1 |
Bai, YR | 1 |
Berisha, S | 1 |
Goda, A | 1 |
Kastrati, A | 1 |
Frasheri, A | 1 |
Popa, Y | 1 |
1 trial available for nifedipine and Intraventricular Septal Defects
Article | Year |
---|---|
Improvement of exercise capacity after nifedipine in patients with Eisenmenger syndrome complicating ventricular septal defect.
Topics: Administration, Oral; Adult; Cardiac Output; Echocardiography, Doppler; Eisenmenger Complex; Exercis | 1991 |
5 other studies available for nifedipine and Intraventricular Septal Defects
Article | Year |
---|---|
Maternal hypoxia associated with nifedipine for threatened preterm labour.
Topics: Adult; Dyspnea; Female; Heart Septal Defects, Ventricular; Humans; Hypoxia; Nifedipine; Obstetric La | 2004 |
Evaluation of pulmonary artery banding in the setting of ventricular septal defects and severely elevated pulmonary vascular resistance.
Topics: Adolescent; Cardiac Catheterization; Child; Comorbidity; Constriction; Coronary Circulation; Fatal O | 2006 |
[Hemodynamic effects of nifedipine on pulmonary hypertension secondary to congenital heart disease with shunts].
Topics: Adolescent; Adult; Child; Ductus Arteriosus, Patent; Female; Heart Septal Defects, Ventricular; Hemo | 1990 |
[Therapeutic effects of nifedipine in pulmonary hypertension secondary to congenital heart disease].
Topics: Adolescent; Adult; Child; Ductus Arteriosus, Patent; Female; Heart Septal Defects, Ventricular; Hemo | 1989 |
Acute haemodynamic effects of nifedipine in patients with ventricular septal defect.
Topics: Adolescent; Blood Pressure; Child; Female; Heart Rate; Heart Septal Defects, Ventricular; Hemodynami | 1988 |